The company initially filed for Chapter 11 bankruptcy protection in February. At that time the company asked the court to continue business practices and a potential sale of assets during the bankruptcy process, according to SEC filings.
InVivo Therapeutics’ implants are designed for patients with acute thoracic spinal cord injuries, according to its website.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
